human snai1 Search Results


94
Genecopoeia snai1 promoter
Snai1 Promoter, supplied by Genecopoeia, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/snai1 promoter/product/Genecopoeia
Average 94 stars, based on 1 article reviews
snai1 promoter - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

92
OriGene snail1
Snail1, supplied by OriGene, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/snail1/product/OriGene
Average 92 stars, based on 1 article reviews
snail1 - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier

90
OriGene snail
Snail, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/snail/product/OriGene
Average 90 stars, based on 1 article reviews
snail - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
OriGene snai1
Snai1, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/snai1/product/OriGene
Average 90 stars, based on 1 article reviews
snai1 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Ribobio co snai1 sirna
Snai1 Sirna, supplied by Ribobio co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/snai1 sirna/product/Ribobio co
Average 90 stars, based on 1 article reviews
snai1 sirna - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Human Protein Atlas snai1 protein
Expression of <t>SNAI1</t> in tumor tissues and compared to normal control tissues. A . Tumor tissues and compared to normal control tissues. B . Different stages. C . Metastasis status
Snai1 Protein, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/snai1 protein/product/Human Protein Atlas
Average 90 stars, based on 1 article reviews
snai1 protein - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Fasmac Co Ltd human snai1 -reverse
PKCγ expression is associated with the epithelial properties of CRC cells (A) The expression of PKCγ and E-cadherin in CaCo-2, WiDr, DLD-1, SW480, SW620, Lovo, and HCT116 cells was quantified using western blotting. The correlation between PKCγ and E-cadherin expression was assessed using Pearson’s product-moment correlation test. (B) Western blot analyses of PKCγ and other marker proteins in DLD-1 and SW480 cells expressing <t>SNAI1.</t> (C) The relative expression levels of CDH1 (E-cadherin) and PRKCG (PKCγ) normalized to that of GAPDH , were determined by qPCR analyses in DLD-1 and SW480 cells expressing SNAI1 (n = 6, each). Data represent means ± SD. Statistical analysis was performed using Student’s t test. ∗∗p < 0.01; ∗∗∗p < 0.001. See also <xref ref-type=Figures S1 and , and Table S1 . " width="250" height="auto" />
Human Snai1 Reverse, supplied by Fasmac Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human snai1 -reverse/product/Fasmac Co Ltd
Average 90 stars, based on 1 article reviews
human snai1 -reverse - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Metabion International AG human snai1
Endocytosis of EpCAM during mesodermal differentiation of ESC (A) Left: EpCAM expression in E14TG2α ESC under pluripotency (day 0, D0) and following mesodermal differentiation (see ) was analyzed with Alexa-488-labeled specific antibody. Shown are scatter dot plots with means and SD of n = 3 independent experiments performed in duplicates. Middle and right: EpCAM endocytosis (middle) and membrane recycling (right) was assessed in E14TG2α ESC under pluripotency (day 0, D0) and following mesodermal differentiation. Shown are scatter dot plots with means and SD of n = 3 independent experiments performed in duplicates. Student's t test; ∗∗ 0.01, ∗∗∗ 0.001, ∗∗∗∗ 0.0001. (B) EpCAM expression in E14TG2α ESC under pluripotency (day 0, D0) and following mesodermal differentiation was analyzed with Alexa-488-labeled specific antibody. Shown are representative examples of unstained pluripotent ESCs and stained pluripotent (D0) and mesodermally differentiated ESCs (D5) in gated dot plots from n = 3 independent experiments performed in duplicates. (C) Expression of pluripotency markers Sox2, Oct3/4 and Nanog, and mesodermal markers α-CAA and vimentin was quantified by qRT-PCR in E14TG2α ESC under pluripotency (day 0, D0) and following mesodermal differentiation. Shown are scatter dot plots with means and SD of n = 3 independent experiments performed in triplicates. Student's t test is indicated. ∗∗ ≤0.01; ∗∗∗∗ ≤0.0001. (D) Left: EpCAM expression in Kyse30 carcinoma cells under control (Ctrl.) and following TGFβ treatment (TGFβ) (see ) was analyzed with Alexa-488-labeled specific antibody. Shown are scatter dot plots with means and SD of n = 3 independent experiments performed in duplicates. Middle and right: EpCAM endocytosis (middle) and membrane recycling (right) was assessed in Kyse30 cells under control (Ctrl.) and following TGFβ treatment (TGFβ). Shown are scatter dot plots with means and SD of n = 3 independent experiments performed in duplicates. Student's t test; ∗∗ 0.01, ∗∗∗∗ 0.0001. (E) The mRNA expression of EMT transcription factors ZEB1/2, <t>SNAI1/2,</t> and TWIST was quantified by qRT-PCR in Kyse30 cells under control (Ctrl.) and following TGFβ treatment (TGFβ). Shown are scatter dot plots with means and SD of n = 3 independent experiments performed in triplicates. Student's t test; ∗∗∗∗ 0.0001, n.s. not significant.
Human Snai1, supplied by Metabion International AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human snai1/product/Metabion International AG
Average 90 stars, based on 1 article reviews
human snai1 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Genechem lv-snai1-rnai #1
Endocytosis of EpCAM during mesodermal differentiation of ESC (A) Left: EpCAM expression in E14TG2α ESC under pluripotency (day 0, D0) and following mesodermal differentiation (see ) was analyzed with Alexa-488-labeled specific antibody. Shown are scatter dot plots with means and SD of n = 3 independent experiments performed in duplicates. Middle and right: EpCAM endocytosis (middle) and membrane recycling (right) was assessed in E14TG2α ESC under pluripotency (day 0, D0) and following mesodermal differentiation. Shown are scatter dot plots with means and SD of n = 3 independent experiments performed in duplicates. Student's t test; ∗∗ 0.01, ∗∗∗ 0.001, ∗∗∗∗ 0.0001. (B) EpCAM expression in E14TG2α ESC under pluripotency (day 0, D0) and following mesodermal differentiation was analyzed with Alexa-488-labeled specific antibody. Shown are representative examples of unstained pluripotent ESCs and stained pluripotent (D0) and mesodermally differentiated ESCs (D5) in gated dot plots from n = 3 independent experiments performed in duplicates. (C) Expression of pluripotency markers Sox2, Oct3/4 and Nanog, and mesodermal markers α-CAA and vimentin was quantified by qRT-PCR in E14TG2α ESC under pluripotency (day 0, D0) and following mesodermal differentiation. Shown are scatter dot plots with means and SD of n = 3 independent experiments performed in triplicates. Student's t test is indicated. ∗∗ ≤0.01; ∗∗∗∗ ≤0.0001. (D) Left: EpCAM expression in Kyse30 carcinoma cells under control (Ctrl.) and following TGFβ treatment (TGFβ) (see ) was analyzed with Alexa-488-labeled specific antibody. Shown are scatter dot plots with means and SD of n = 3 independent experiments performed in duplicates. Middle and right: EpCAM endocytosis (middle) and membrane recycling (right) was assessed in Kyse30 cells under control (Ctrl.) and following TGFβ treatment (TGFβ). Shown are scatter dot plots with means and SD of n = 3 independent experiments performed in duplicates. Student's t test; ∗∗ 0.01, ∗∗∗∗ 0.0001. (E) The mRNA expression of EMT transcription factors ZEB1/2, <t>SNAI1/2,</t> and TWIST was quantified by qRT-PCR in Kyse30 cells under control (Ctrl.) and following TGFβ treatment (TGFβ). Shown are scatter dot plots with means and SD of n = 3 independent experiments performed in triplicates. Student's t test; ∗∗∗∗ 0.0001, n.s. not significant.
Lv Snai1 Rnai #1, supplied by Genechem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lv-snai1-rnai #1/product/Genechem
Average 90 stars, based on 1 article reviews
lv-snai1-rnai #1 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

94
Genecopoeia promoter reporter clone for human snai1
Endocytosis of EpCAM during mesodermal differentiation of ESC (A) Left: EpCAM expression in E14TG2α ESC under pluripotency (day 0, D0) and following mesodermal differentiation (see ) was analyzed with Alexa-488-labeled specific antibody. Shown are scatter dot plots with means and SD of n = 3 independent experiments performed in duplicates. Middle and right: EpCAM endocytosis (middle) and membrane recycling (right) was assessed in E14TG2α ESC under pluripotency (day 0, D0) and following mesodermal differentiation. Shown are scatter dot plots with means and SD of n = 3 independent experiments performed in duplicates. Student's t test; ∗∗ 0.01, ∗∗∗ 0.001, ∗∗∗∗ 0.0001. (B) EpCAM expression in E14TG2α ESC under pluripotency (day 0, D0) and following mesodermal differentiation was analyzed with Alexa-488-labeled specific antibody. Shown are representative examples of unstained pluripotent ESCs and stained pluripotent (D0) and mesodermally differentiated ESCs (D5) in gated dot plots from n = 3 independent experiments performed in duplicates. (C) Expression of pluripotency markers Sox2, Oct3/4 and Nanog, and mesodermal markers α-CAA and vimentin was quantified by qRT-PCR in E14TG2α ESC under pluripotency (day 0, D0) and following mesodermal differentiation. Shown are scatter dot plots with means and SD of n = 3 independent experiments performed in triplicates. Student's t test is indicated. ∗∗ ≤0.01; ∗∗∗∗ ≤0.0001. (D) Left: EpCAM expression in Kyse30 carcinoma cells under control (Ctrl.) and following TGFβ treatment (TGFβ) (see ) was analyzed with Alexa-488-labeled specific antibody. Shown are scatter dot plots with means and SD of n = 3 independent experiments performed in duplicates. Middle and right: EpCAM endocytosis (middle) and membrane recycling (right) was assessed in Kyse30 cells under control (Ctrl.) and following TGFβ treatment (TGFβ). Shown are scatter dot plots with means and SD of n = 3 independent experiments performed in duplicates. Student's t test; ∗∗ 0.01, ∗∗∗∗ 0.0001. (E) The mRNA expression of EMT transcription factors ZEB1/2, <t>SNAI1/2,</t> and TWIST was quantified by qRT-PCR in Kyse30 cells under control (Ctrl.) and following TGFβ treatment (TGFβ). Shown are scatter dot plots with means and SD of n = 3 independent experiments performed in triplicates. Student's t test; ∗∗∗∗ 0.0001, n.s. not significant.
Promoter Reporter Clone For Human Snai1, supplied by Genecopoeia, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/promoter reporter clone for human snai1/product/Genecopoeia
Average 94 stars, based on 1 article reviews
promoter reporter clone for human snai1 - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

90
OriGene snail (snai1) (nm_005985) human 3' utr clone
Endocytosis of EpCAM during mesodermal differentiation of ESC (A) Left: EpCAM expression in E14TG2α ESC under pluripotency (day 0, D0) and following mesodermal differentiation (see ) was analyzed with Alexa-488-labeled specific antibody. Shown are scatter dot plots with means and SD of n = 3 independent experiments performed in duplicates. Middle and right: EpCAM endocytosis (middle) and membrane recycling (right) was assessed in E14TG2α ESC under pluripotency (day 0, D0) and following mesodermal differentiation. Shown are scatter dot plots with means and SD of n = 3 independent experiments performed in duplicates. Student's t test; ∗∗ 0.01, ∗∗∗ 0.001, ∗∗∗∗ 0.0001. (B) EpCAM expression in E14TG2α ESC under pluripotency (day 0, D0) and following mesodermal differentiation was analyzed with Alexa-488-labeled specific antibody. Shown are representative examples of unstained pluripotent ESCs and stained pluripotent (D0) and mesodermally differentiated ESCs (D5) in gated dot plots from n = 3 independent experiments performed in duplicates. (C) Expression of pluripotency markers Sox2, Oct3/4 and Nanog, and mesodermal markers α-CAA and vimentin was quantified by qRT-PCR in E14TG2α ESC under pluripotency (day 0, D0) and following mesodermal differentiation. Shown are scatter dot plots with means and SD of n = 3 independent experiments performed in triplicates. Student's t test is indicated. ∗∗ ≤0.01; ∗∗∗∗ ≤0.0001. (D) Left: EpCAM expression in Kyse30 carcinoma cells under control (Ctrl.) and following TGFβ treatment (TGFβ) (see ) was analyzed with Alexa-488-labeled specific antibody. Shown are scatter dot plots with means and SD of n = 3 independent experiments performed in duplicates. Middle and right: EpCAM endocytosis (middle) and membrane recycling (right) was assessed in Kyse30 cells under control (Ctrl.) and following TGFβ treatment (TGFβ). Shown are scatter dot plots with means and SD of n = 3 independent experiments performed in duplicates. Student's t test; ∗∗ 0.01, ∗∗∗∗ 0.0001. (E) The mRNA expression of EMT transcription factors ZEB1/2, <t>SNAI1/2,</t> and TWIST was quantified by qRT-PCR in Kyse30 cells under control (Ctrl.) and following TGFβ treatment (TGFβ). Shown are scatter dot plots with means and SD of n = 3 independent experiments performed in triplicates. Student's t test; ∗∗∗∗ 0.0001, n.s. not significant.
Snail (Snai1) (Nm 005985) Human 3' Utr Clone, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/snail (snai1) (nm_005985) human 3' utr clone/product/OriGene
Average 90 stars, based on 1 article reviews
snail (snai1) (nm_005985) human 3' utr clone - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Expression of SNAI1 in tumor tissues and compared to normal control tissues. A . Tumor tissues and compared to normal control tissues. B . Different stages. C . Metastasis status

Journal: Journal of Cardiothoracic Surgery

Article Title: SNAI1: a key modulator of survival in lung squamous cell carcinoma and its association with metastasis

doi: 10.1186/s13019-024-03044-8

Figure Lengend Snippet: Expression of SNAI1 in tumor tissues and compared to normal control tissues. A . Tumor tissues and compared to normal control tissues. B . Different stages. C . Metastasis status

Article Snippet: The subcellular localization of the SNAI1 protein within LUSC tissue cells was investigated using immunohistochemistry data sourced from the Human Protein Atlas database.

Techniques: Expressing, Control

Optimal Threshold Analysis of SNAI1 expression. Optimal threshold analysis software(X-tile Software) was employed to stratify SNAI1 expression into three-tier ( A , B ) and two-tier ( C , D ) classifications for patient prognosis analysis. Impact of Metastasis status ( E ) and SNAI1 Expression ( F ) on LUSC Prognosis

Journal: Journal of Cardiothoracic Surgery

Article Title: SNAI1: a key modulator of survival in lung squamous cell carcinoma and its association with metastasis

doi: 10.1186/s13019-024-03044-8

Figure Lengend Snippet: Optimal Threshold Analysis of SNAI1 expression. Optimal threshold analysis software(X-tile Software) was employed to stratify SNAI1 expression into three-tier ( A , B ) and two-tier ( C , D ) classifications for patient prognosis analysis. Impact of Metastasis status ( E ) and SNAI1 Expression ( F ) on LUSC Prognosis

Article Snippet: The subcellular localization of the SNAI1 protein within LUSC tissue cells was investigated using immunohistochemistry data sourced from the Human Protein Atlas database.

Techniques: Expressing, Software

Validation of SNAI1 expression and prognosis correlation in multiple LUSC datasets (Gene Expression Omnibus (GEO) database: GSE3141, GSE29013, GSE4573, GSE157011)

Journal: Journal of Cardiothoracic Surgery

Article Title: SNAI1: a key modulator of survival in lung squamous cell carcinoma and its association with metastasis

doi: 10.1186/s13019-024-03044-8

Figure Lengend Snippet: Validation of SNAI1 expression and prognosis correlation in multiple LUSC datasets (Gene Expression Omnibus (GEO) database: GSE3141, GSE29013, GSE4573, GSE157011)

Article Snippet: The subcellular localization of the SNAI1 protein within LUSC tissue cells was investigated using immunohistochemistry data sourced from the Human Protein Atlas database.

Techniques: Expressing

Clinical characteristics

Journal: Journal of Cardiothoracic Surgery

Article Title: SNAI1: a key modulator of survival in lung squamous cell carcinoma and its association with metastasis

doi: 10.1186/s13019-024-03044-8

Figure Lengend Snippet: Clinical characteristics

Article Snippet: The subcellular localization of the SNAI1 protein within LUSC tissue cells was investigated using immunohistochemistry data sourced from the Human Protein Atlas database.

Techniques:

Univariate and multivariate Cox regression analyses

Journal: Journal of Cardiothoracic Surgery

Article Title: SNAI1: a key modulator of survival in lung squamous cell carcinoma and its association with metastasis

doi: 10.1186/s13019-024-03044-8

Figure Lengend Snippet: Univariate and multivariate Cox regression analyses

Article Snippet: The subcellular localization of the SNAI1 protein within LUSC tissue cells was investigated using immunohistochemistry data sourced from the Human Protein Atlas database.

Techniques:

The expression of SNAI1 protein in LUSC associated with prognosis

Journal: Journal of Cardiothoracic Surgery

Article Title: SNAI1: a key modulator of survival in lung squamous cell carcinoma and its association with metastasis

doi: 10.1186/s13019-024-03044-8

Figure Lengend Snippet: The expression of SNAI1 protein in LUSC associated with prognosis

Article Snippet: The subcellular localization of the SNAI1 protein within LUSC tissue cells was investigated using immunohistochemistry data sourced from the Human Protein Atlas database.

Techniques: Expressing

The hallmark gene sets correlated with  SNAI1  expression

Journal: Journal of Cardiothoracic Surgery

Article Title: SNAI1: a key modulator of survival in lung squamous cell carcinoma and its association with metastasis

doi: 10.1186/s13019-024-03044-8

Figure Lengend Snippet: The hallmark gene sets correlated with SNAI1 expression

Article Snippet: The subcellular localization of the SNAI1 protein within LUSC tissue cells was investigated using immunohistochemistry data sourced from the Human Protein Atlas database.

Techniques:

SNAI1 Expression Correlates with Immune Checkpoint Molecules in LUSC

Journal: Journal of Cardiothoracic Surgery

Article Title: SNAI1: a key modulator of survival in lung squamous cell carcinoma and its association with metastasis

doi: 10.1186/s13019-024-03044-8

Figure Lengend Snippet: SNAI1 Expression Correlates with Immune Checkpoint Molecules in LUSC

Article Snippet: The subcellular localization of the SNAI1 protein within LUSC tissue cells was investigated using immunohistochemistry data sourced from the Human Protein Atlas database.

Techniques: Expressing

Identification of potential molecular targeted drugs for  SNAI1

Journal: Journal of Cardiothoracic Surgery

Article Title: SNAI1: a key modulator of survival in lung squamous cell carcinoma and its association with metastasis

doi: 10.1186/s13019-024-03044-8

Figure Lengend Snippet: Identification of potential molecular targeted drugs for SNAI1

Article Snippet: The subcellular localization of the SNAI1 protein within LUSC tissue cells was investigated using immunohistochemistry data sourced from the Human Protein Atlas database.

Techniques:

PKCγ expression is associated with the epithelial properties of CRC cells (A) The expression of PKCγ and E-cadherin in CaCo-2, WiDr, DLD-1, SW480, SW620, Lovo, and HCT116 cells was quantified using western blotting. The correlation between PKCγ and E-cadherin expression was assessed using Pearson’s product-moment correlation test. (B) Western blot analyses of PKCγ and other marker proteins in DLD-1 and SW480 cells expressing SNAI1. (C) The relative expression levels of CDH1 (E-cadherin) and PRKCG (PKCγ) normalized to that of GAPDH , were determined by qPCR analyses in DLD-1 and SW480 cells expressing SNAI1 (n = 6, each). Data represent means ± SD. Statistical analysis was performed using Student’s t test. ∗∗p < 0.01; ∗∗∗p < 0.001. See also <xref ref-type=Figures S1 and , and Table S1 . " width="100%" height="100%">

Journal: iScience

Article Title: Downregulation of protein kinase C gamma reduces epithelial property and enhances malignant phenotypes in colorectal cancer cells

doi: 10.1016/j.isci.2022.105501

Figure Lengend Snippet: PKCγ expression is associated with the epithelial properties of CRC cells (A) The expression of PKCγ and E-cadherin in CaCo-2, WiDr, DLD-1, SW480, SW620, Lovo, and HCT116 cells was quantified using western blotting. The correlation between PKCγ and E-cadherin expression was assessed using Pearson’s product-moment correlation test. (B) Western blot analyses of PKCγ and other marker proteins in DLD-1 and SW480 cells expressing SNAI1. (C) The relative expression levels of CDH1 (E-cadherin) and PRKCG (PKCγ) normalized to that of GAPDH , were determined by qPCR analyses in DLD-1 and SW480 cells expressing SNAI1 (n = 6, each). Data represent means ± SD. Statistical analysis was performed using Student’s t test. ∗∗p < 0.01; ∗∗∗p < 0.001. See also Figures S1 and , and Table S1 .

Article Snippet: human SNAI1 -Reverse; CGCCTGGCACTGGTACTTCTT , FASMAC , N/A.

Techniques: Expressing, Western Blot, Marker

Journal: iScience

Article Title: Downregulation of protein kinase C gamma reduces epithelial property and enhances malignant phenotypes in colorectal cancer cells

doi: 10.1016/j.isci.2022.105501

Figure Lengend Snippet:

Article Snippet: human SNAI1 -Reverse; CGCCTGGCACTGGTACTTCTT , FASMAC , N/A.

Techniques: Recombinant, Reporter Assay, Expressing, Negative Control, Plasmid Preparation, Software

Endocytosis of EpCAM during mesodermal differentiation of ESC (A) Left: EpCAM expression in E14TG2α ESC under pluripotency (day 0, D0) and following mesodermal differentiation (see ) was analyzed with Alexa-488-labeled specific antibody. Shown are scatter dot plots with means and SD of n = 3 independent experiments performed in duplicates. Middle and right: EpCAM endocytosis (middle) and membrane recycling (right) was assessed in E14TG2α ESC under pluripotency (day 0, D0) and following mesodermal differentiation. Shown are scatter dot plots with means and SD of n = 3 independent experiments performed in duplicates. Student's t test; ∗∗ 0.01, ∗∗∗ 0.001, ∗∗∗∗ 0.0001. (B) EpCAM expression in E14TG2α ESC under pluripotency (day 0, D0) and following mesodermal differentiation was analyzed with Alexa-488-labeled specific antibody. Shown are representative examples of unstained pluripotent ESCs and stained pluripotent (D0) and mesodermally differentiated ESCs (D5) in gated dot plots from n = 3 independent experiments performed in duplicates. (C) Expression of pluripotency markers Sox2, Oct3/4 and Nanog, and mesodermal markers α-CAA and vimentin was quantified by qRT-PCR in E14TG2α ESC under pluripotency (day 0, D0) and following mesodermal differentiation. Shown are scatter dot plots with means and SD of n = 3 independent experiments performed in triplicates. Student's t test is indicated. ∗∗ ≤0.01; ∗∗∗∗ ≤0.0001. (D) Left: EpCAM expression in Kyse30 carcinoma cells under control (Ctrl.) and following TGFβ treatment (TGFβ) (see ) was analyzed with Alexa-488-labeled specific antibody. Shown are scatter dot plots with means and SD of n = 3 independent experiments performed in duplicates. Middle and right: EpCAM endocytosis (middle) and membrane recycling (right) was assessed in Kyse30 cells under control (Ctrl.) and following TGFβ treatment (TGFβ). Shown are scatter dot plots with means and SD of n = 3 independent experiments performed in duplicates. Student's t test; ∗∗ 0.01, ∗∗∗∗ 0.0001. (E) The mRNA expression of EMT transcription factors ZEB1/2, SNAI1/2, and TWIST was quantified by qRT-PCR in Kyse30 cells under control (Ctrl.) and following TGFβ treatment (TGFβ). Shown are scatter dot plots with means and SD of n = 3 independent experiments performed in triplicates. Student's t test; ∗∗∗∗ 0.0001, n.s. not significant.

Journal: iScience

Article Title: Interactome analysis reveals endocytosis and membrane recycling of EpCAM during differentiation of embryonic stem cells and carcinoma cells

doi: 10.1016/j.isci.2021.103179

Figure Lengend Snippet: Endocytosis of EpCAM during mesodermal differentiation of ESC (A) Left: EpCAM expression in E14TG2α ESC under pluripotency (day 0, D0) and following mesodermal differentiation (see ) was analyzed with Alexa-488-labeled specific antibody. Shown are scatter dot plots with means and SD of n = 3 independent experiments performed in duplicates. Middle and right: EpCAM endocytosis (middle) and membrane recycling (right) was assessed in E14TG2α ESC under pluripotency (day 0, D0) and following mesodermal differentiation. Shown are scatter dot plots with means and SD of n = 3 independent experiments performed in duplicates. Student's t test; ∗∗ 0.01, ∗∗∗ 0.001, ∗∗∗∗ 0.0001. (B) EpCAM expression in E14TG2α ESC under pluripotency (day 0, D0) and following mesodermal differentiation was analyzed with Alexa-488-labeled specific antibody. Shown are representative examples of unstained pluripotent ESCs and stained pluripotent (D0) and mesodermally differentiated ESCs (D5) in gated dot plots from n = 3 independent experiments performed in duplicates. (C) Expression of pluripotency markers Sox2, Oct3/4 and Nanog, and mesodermal markers α-CAA and vimentin was quantified by qRT-PCR in E14TG2α ESC under pluripotency (day 0, D0) and following mesodermal differentiation. Shown are scatter dot plots with means and SD of n = 3 independent experiments performed in triplicates. Student's t test is indicated. ∗∗ ≤0.01; ∗∗∗∗ ≤0.0001. (D) Left: EpCAM expression in Kyse30 carcinoma cells under control (Ctrl.) and following TGFβ treatment (TGFβ) (see ) was analyzed with Alexa-488-labeled specific antibody. Shown are scatter dot plots with means and SD of n = 3 independent experiments performed in duplicates. Middle and right: EpCAM endocytosis (middle) and membrane recycling (right) was assessed in Kyse30 cells under control (Ctrl.) and following TGFβ treatment (TGFβ). Shown are scatter dot plots with means and SD of n = 3 independent experiments performed in duplicates. Student's t test; ∗∗ 0.01, ∗∗∗∗ 0.0001. (E) The mRNA expression of EMT transcription factors ZEB1/2, SNAI1/2, and TWIST was quantified by qRT-PCR in Kyse30 cells under control (Ctrl.) and following TGFβ treatment (TGFβ). Shown are scatter dot plots with means and SD of n = 3 independent experiments performed in triplicates. Student's t test; ∗∗∗∗ 0.0001, n.s. not significant.

Article Snippet: Human SNAI1 , Metabion, Germany , Forward: AGATGAGCATTGGCAGCGAG Reverse: TGGGAAGCCTAACTACAGCGA.

Techniques: Expressing, Labeling, Membrane, Staining, Quantitative RT-PCR, Control

Journal: iScience

Article Title: Interactome analysis reveals endocytosis and membrane recycling of EpCAM during differentiation of embryonic stem cells and carcinoma cells

doi: 10.1016/j.isci.2021.103179

Figure Lengend Snippet:

Article Snippet: Human SNAI1 , Metabion, Germany , Forward: AGATGAGCATTGGCAGCGAG Reverse: TGGGAAGCCTAACTACAGCGA.

Techniques: Recombinant, SYBR Green Assay, Plasmid Preparation, Modification, Clone Assay, Amplification, Software